lysophosphatidic acid has been researched along with Libman-Sacks Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, M; Ishizuka, T; Koizumi, A; Nagata, W; Nakagawa, K; Satoh, Y; Takahashi, S | 1 |
| Boilard, E; Bourgoin, SG; Duchez, AC; Fortin, P; Hasse, S | 1 |
2 other study(ies) available for lysophosphatidic acid and Libman-Sacks Disease
| Article | Year |
|---|---|
Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Topics: Animals; Depression; Disease Models, Animal; Fluorescein; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Mice; Mice, Inbred MRL lpr; Microglia | 2023 |
Interplay between LPA2 and LPA3 in LPA-mediated phosphatidylserine cell surface exposure and extracellular vesicles release by erythrocytes.
Topics: Cell Membrane; Erythrocytes; Extracellular Vesicles; Female; Humans; Lupus Erythematosus, Systemic; Lysophospholipids; Male; Phosphatidylserines; Receptors, Lysophosphatidic Acid | 2021 |